DJIA 15,354.40 121.18 0.80%
NASDAQ 3,498.97 33.73 0.97%
S&P 500 1,667.47 17.00 1.03%

Myriad Genetics

NASDAQ: MYGN

32.93 -0.20 (-0.60%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MYGN $32.93 -0.60%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $33.25
Previous Close $33.13
Daily Range $32.73 - $33.43
52-Week Range $22.02 - $34.70
Market Cap $2.6B
P/E Ratio 21.10
Dividend (Yield) $0.00 (0.0%)
Volume 1,685,179
Average Daily Volume 1,249,181
Current FY EPS $1.66

Sector

Services

Industry

Diversified Services

Myriad Genetics (MYGN) Description

Myriad Genetics is focused on developing and marketing novel molecular diagnostic products. Website: http://www.myriad.com/

News & Commentary

CE Mark for STJ's ILUMIEN OPTIS - Analyst Blog

Stryker Reiterated at Neutral - Analyst Blog

SGEN's Adcetris under FDA Review - Analyst Blog

Covidien Prices Senior Notes - Analyst Blog

Company That Sells Angelina Jolie’s Blood Test

Angelina Jolie's Selfless Act Heightens Breast Cancer Awareness

Jolie's personal experiences brings the dangers of breast cancer into new light and also gives hope to current and future breast cancer sufferers thanks to improving therapies and diagnostic tests.

Genomic Health's New Prostate Test May Extend The Stock's Upward Climb

Much Awaited Test Launch by Genomic - Analyst Blog

Myriad Soars Higher on Celeb Clout - Analyst Blog

Myriad Soars Higher on Celeb Clout - Analyst Blog

The Angelina Jolie Connection: The Debate Over Patenting Human Genes

See More MYGN News...

MYGN's Top Competitors

MYGN $32.93 (-0.60%)
Current stock: MYGN
AMGN $105.63 (0.63%)
Current stock: AMGN
GILD $56.30 (2.44%)
Current stock: GILD
BIIB $226.85 (-0.50%)
Current stock: BIIB